Justdapa-V 10/100 Tablet SR: Combination Treatment for Type 2 Diabetes

Justdapa-V 10/100 Tablet SR combines the powerful action of Dapagliflozin (10mg) and Vildagliptin (100mg) in a single tablet. This unique combination offers comprehensive management for type 2 diabetes by addressing different aspects of blood glucose control.

Dapagliflozin acts as a SGLT2 inhibitor, blocking the kidneys' reabsorption of glucose, resulting in increased urinary excretion and lower blood sugar levels.
Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, increasing incretin hormone activity, which stimulates insulin release and reduces glucagon secretion for improved glycemic control.

The combination of these medications works synergistically to provide effective and long-lasting blood glucose management. This convenient, once-daily tablet format simplifies daily medication routines while maximizing treatment effectiveness.

Please consult with your healthcare professional before use.